Acclarent to Reveal New Data and Innovations to Advance Minimally Invasive ENT Procedures at ARS and AAO 2022 Meetings
IRVINE, Calif., Sept. 8, 2022 /PRNewswire/ — Acclarent, Inc., part of Johnson & Johnson MedTech,* and a leader in developing minimally invasive Ear, Nose & Throat (ENT) technologies, will showcase its latest products and clinical research at the 68th Annual Meeting of the American…
Comments Off on Acclarent to Reveal New Data and Innovations to Advance Minimally Invasive ENT Procedures at ARS and AAO 2022 Meetings